Article
Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients.
Journal of neurology - 1 Oct 1999
Mäurer M, Kruse N, Giess R, Kyriallis K, Toyka K V, Rieckmann P
Abstract excerpt
Tumor necrosis factor-alpha (TNFalpha) is a pluripotent proinflammatory cytokine and is thought to play an important role in the inflammatory process of multiple sclerosis (MS). A G-->A transition in the TNFalpha promotor at position -308 (TNF2 allele) has been shown to be associated with increased TNFalpha production. This study was designed to detect wether the TNF2 allele is associated with disease progression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
